BACKGROUND/AIMS: Knowledge regarding genetic factors that influence pancreatic cancer risk is currently limited. To identify novel pancreatic cancer susceptibility loci, we conducted a two-stage genome-wide association study. METHODS: The Affymetrix Genome-Wide Human SNP Array 6.0 and DNA pooling were used in the screening stage. Twenty-six single-nucleotide polymorphisms (SNPs) were selected for follow-up. These 26 lead SNPs and additionally selected tagSNPs for the regions around the lead SNPs were evaluated by individual genotyping of the pooling population and an independent validation population. RESULTS: Of the lead SNPs, the strongest association was found with rs4820599 located in the gamma-glutamyltransferase 1 (GGT1) gene. This SNP was significantly associated with pancreatic cancer risk in the validation population and the combined dataset (p(allele-based) = 0.019 and p(allele-based) = 0.003, respectively). Statistically significant associations were also observed with two GGT1 tagSNPs: rs2017869 and rs8135987. Lead SNP rs4820599 is in high linkage disequilibrium (LD; pairwise r(2): 0.69) and tagSNP rs2017869 is in strong LD (pairwise r(2): 0.96) with SNP rs5751901, which has been reported to be associated with increased GGT1 serum levels. GGT is expressed in the pancreas and plays a key role in glutathione metabolism. CONCLUSION: Our results suggest that common variation in the GGT1 gene may affect the risk of pancreatic cancer. . Copyright 2010 S. Karger AG, Basel.
BACKGROUND/AIMS: Knowledge regarding genetic factors that influence pancreatic cancer risk is currently limited. To identify novel pancreatic cancer susceptibility loci, we conducted a two-stage genome-wide association study. METHODS: The Affymetrix Genome-Wide Human SNP Array 6.0 and DNA pooling were used in the screening stage. Twenty-six single-nucleotide polymorphisms (SNPs) were selected for follow-up. These 26 lead SNPs and additionally selected tagSNPs for the regions around the lead SNPs were evaluated by individual genotyping of the pooling population and an independent validation population. RESULTS: Of the lead SNPs, the strongest association was found with rs4820599 located in the gamma-glutamyltransferase 1 (GGT1) gene. This SNP was significantly associated with pancreatic cancer risk in the validation population and the combined dataset (p(allele-based) = 0.019 and p(allele-based) = 0.003, respectively). Statistically significant associations were also observed with two GGT1 tagSNPs: rs2017869 and rs8135987. Lead SNP rs4820599 is in high linkage disequilibrium (LD; pairwise r(2): 0.69) and tagSNP rs2017869 is in strong LD (pairwise r(2): 0.96) with SNP rs5751901, which has been reported to be associated with increased GGT1 serum levels. GGT is expressed in the pancreas and plays a key role in glutathione metabolism. CONCLUSION: Our results suggest that common variation in the GGT1 gene may affect the risk of pancreatic cancer. . Copyright 2010 S. Karger AG, Basel.
Authors: A C Tersmette; G M Petersen; G J Offerhaus; F C Falatko; K A Brune; M Goggins; E Rozenblum; R E Wilentz; C J Yeo; J L Cameron; S E Kern; R H Hruban Journal: Clin Cancer Res Date: 2001-03 Impact factor: 12.531
Authors: R H Hruban; G M Petersen; M Goggins; A C Tersmette; G J Offerhaus; F Falatko; C J Yeo; S E Kern Journal: Ann Oncol Date: 1999 Impact factor: 32.976
Authors: H T Lynch; M L Fitzsimmons; T C Smyrk; S J Lanspa; P Watson; J McClellan; J F Lynch Journal: Am J Gastroenterol Date: 1990-01 Impact factor: 10.864
Authors: Alison P Klein; Kieran A Brune; Gloria M Petersen; Michael Goggins; Anne C Tersmette; G Johan A Offerhaus; Constance Griffin; John L Cameron; Charles J Yeo; Scott Kern; Ralph H Hruban Journal: Cancer Res Date: 2004-04-01 Impact factor: 12.701
Authors: Dana K Andersen; Åke Andren-Sandberg; Eric J Duell; Michael Goggins; Murray Korc; Gloria M Petersen; Jill P Smith; David C Whitcomb Journal: Pancreas Date: 2013-11 Impact factor: 3.327
Authors: Matthew B West; Yunyu Chen; Stephanie Wickham; Ann Heroux; Kyle Cahill; Marie H Hanigan; Blaine H M Mooers Journal: J Biol Chem Date: 2013-09-18 Impact factor: 5.157
Authors: Harrison Brand; Brenda Diergaarde; Michael R O'Connell; David C Whitcomb; Randall E Brand Journal: Pancreas Date: 2013-07 Impact factor: 3.327
Authors: Max Leenders; Samsiddhi Bhattacharjee; Paolo Vineis; Victoria Stevens; H Bas Bueno-de-Mesquita; Xiao-Ou Shu; Laufey Amundadottir; Myron Gross; Geoffrey S Tobias; Jean Wactawski-Wende; Alan A Arslan; Eric J Duell; Charles S Fuchs; Steven Gallinger; Patricia Hartge; Robert N Hoover; Elizabeth A Holly; Eric J Jacobs; Alison P Klein; Charles Kooperberg; Andrea LaCroix; Donghui Li; Margaret T Mandelson; Sara H Olson; Gloria Petersen; Harvey A Risch; Kai Yu; Brian M Wolpin; Wei Zheng; Ilir Agalliu; Demetrius Albanes; Marie-Christine Boutron-Ruault; Paige M Bracci; Julie E Buring; Federico Canzian; Kenneth Chang; Stephen J Chanock; Michelle Cotterchio; J Michael Gaziano; Edward L Giovanucci; Michael Goggins; Göran Hallmans; Susan E Hankinson; Judith A Hoffman-Bolton; David J Hunter; Amy Hutchinson; Kevin B Jacobs; Mazda Jenab; Kay-Tee Khaw; Peter Kraft; Vittorio Krogh; Robert C Kurtz; Robert R McWilliams; Julie B Mendelsohn; Alpa V Patel; Kari G Rabe; Elio Riboli; Anne Tjønneland; Dimitrios Trichopoulos; Jarmo Virtamo; Kala Visvanathan; Joanne W Elena; Herbert Yu; Anne Zeleniuch-Jacquotte; Rachael Z Stolzenberg-Solomon Journal: Cancer Causes Control Date: 2013-01-19 Impact factor: 2.506